Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 4/20 | 0.55 |
| ▸ | TRPC6 | Q9Y210 | 1/20 | 0.38 |
| ▸ | CIT | O14578 | 1/20 | 0.36 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.36 |
| ▸ | GAK | O14976 | 1/20 | 0.36 |
| ▸ | STK10 | O94804 | 1/20 | 0.36 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | YES1 | P07947 | 1/20 | 0.36 |
| ▸ | LYN | P07948 | 1/20 | 0.36 |
| ▸ | RET | P07949 | 1/20 | 0.36 |
| ▸ | HCK | P08631 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | PHKG2 | P15735 | 1/20 | 0.36 |
| ▸ | PRKCA | P17252 | 1/20 | 0.36 |
| ▸ | PRKACA | P17612 | 1/20 | 0.36 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5745036 | 1.00 | SLC2A1 (0.55) | SLC2A1TRPC6CITCHEK1GAK | |
| SCHEMBL6079813 | 1.00 | SLC2A1 (0.55) | SLC2A1TRPC6CITCHEK1GAK | |
| SCHEMBL6079872 | 0.90 | SLC2A1 (0.56) | SLC2A1TRPC6KCNH2PDE10A | |
| SCHEMBL6079870 | 0.90 | SLC2A1 (0.56) | SLC2A1TRPC6KCNH2PDE10A | |
| SCHEMBL6079876 | 0.90 | SLC2A1 (0.56) | SLC2A1TRPC6KCNH2PDE10A | |
| SCHEMBL6080909 | 0.87 | SLC2A1 (0.62) | SLC2A1TRPC6KCNH2PDE10A | |
| SCHEMBL6079343 | 0.85 | SLC2A1 (0.53) | SLC2A1KCNH2CDK4CCND1CCND3 | |
| SCHEMBL6079796 | 0.85 | SLC2A1 (0.53) | SLC2A1KCNH2CDK4CCND1CCND3 | |
| SCHEMBL6079334 | 0.85 | SLC2A1 (0.53) | SLC2A1KCNH2CDK4CCND1CCND3 | |
| SCHEMBL6079786 | 0.85 | SLC2A1 (0.53) | SLC2A1KCNH2CDK4CCND1CCND3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060041123-A1 | Antibacterial agents | GLAXO GROUP LIMITED (GB) | 2006-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060041123-A1 | Antibacterial agents | NQO2, NRDC, IFNG | SLC2A1 4409/4885TRPC6 3722/4885CIT 2724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.